The National Aspergillosis CARES Team are excited to announce its membership in European Lung Foundation (ELF) Patient Organisation Network. This collaboration marks a milestone in the team’s commitment to enhancing the lives of individuals affected by aspergillosis.
Founded in 2000 and working in partnership with the European Respiratory Society (ERS), ELF is a patient-led organisation that works internationally to bring patients and the public together with healthcare professionals to improve lung health and advance diagnosis, treatment, and care.
The ELF Patient Organisation Network is a hub for respiratory patient organisations throughout Europe, fostering knowledge exchange, collaboration, and advocacy initiatives to improve respiratory health and well-being across the continent. Membership of the network provides the CARES Team with access to invaluable resources, expertise, and opportunities to positively impact the lives of those living with aspergillosis.
As an active participant in this network, the NAC CARES Team will contribute expertise, raise awareness at both national and European levels, and help drive positive change. In addition to knowledge sharing and advocacy, the ELF Patient Organisation Network offers opportunities for networking and collaboration. By connecting with like-minded organisations, the team can establish partnerships, share experiences, and collaborate on joint initiatives to create a more supportive environment for individuals living with aspergillosis in Europe.
You can read more about ELF here: https://europeanlung.org/en/
Share this post
Latest News posts
When Scents Cause Symptoms: What Patients Say About Odour Triggers
November 10, 2025
Understanding Risk from Aspergillosis — and What’s Improving
November 10, 2025
Understanding Risk: How Common Is “Rare”?
November 10, 2025
Aspergillosis & Asthma: When Risks Peak Through the Year
November 10, 2025
🏗️ Damp, Dust and Indoor Air Quality
November 10, 2025
🫁 Understanding Chronic Cough in Aspergillosis
October 30, 2025
💼 Aspergillosis, Scent Sensitivity, and the Workplace
October 30, 2025
🩺 Article 1: Managing Side Effects of Aspergillosis Treatments
October 30, 2025
⚠️ Omeprazole and PPIs: What’s Behind the Recent Warning?
October 30, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
